Background Stroke after transcatheter aortic valve implantation (TAVI) is an infrequent but serious complication with ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2025. Recent Highlights. Q3 ...

A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.

In ENCIRCLE, TMVR was performed in very ill patients with symptomatic mitral valve disease unsuitable for surgery or commercially available transcatheter edge-to-edge repair (TEER). Given the huge ...

CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating ...